Quarterly 13F snapshot: US-listed longs only, no performance figures — 13F data cannot support them.
Reported portfolio value by quarter (12 quarters reported)
$145M in Q4 2017 → $17.3M now. Hover for any quarter.
As reported for the quarter ended September 30, 2020. Activity is the change in share count since the prior quarter's filing.
| Holding | % of portfolio | Activity | Shares | Value |
|---|---|---|---|---|
| Bellerophon Therapeutics Inc | 67.7% | Unchanged | 1,153,846 | $11.7M |
| EB Ekso Bionics Hldgs Inc | 21.2% | Unchanged | 774,400 | $3.68M |
| Scynexis Inc | 7.9% | New | 311,143 | $1.37M |
| KH Kadmon Hldgs Inc | 2.3% | New | 100,184 | $393K |
| Corvus Pharmaceuticals Inc | 0.9% | Unchanged | 38,010 | $152K |
What changed each quarter, from the filings' own share counts. Largest moves first; most recent 8 quarters.
quarter ended September 30, 2020 · filed November 12, 2020
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Scynexis Inc | Exited | −3,111,436 | −$2.34M | — |
| Scynexis Inc | New | +311,143 | +$1.37M | 7.9% |
| KH Kadmon Hldgs Inc | New | +100,184 | +$393K | 2.3% |
quarter ended June 30, 2020 · filed August 14, 2020
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Bellerophon Therapeutics Inc | Added | +600,596 | +$7.54M | 61.8% |
| Scynexis Inc | Added | +3,025,361 | +$2.27M | 10.0% |
| KH Kadmon Hldgs Inc | Exited | −30,000 | −$126K | — |
| Tracon Pharmaceuticals Inc | Exited | −18,107 | −$31K | — |
quarter ended March 31, 2020 · filed May 15, 2020
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Viewray Inc | Exited | −6,842,975 | −$28.9M | — |
| EB Ekso Bionics Hldgs Inc | Exited | −20,534,898 | −$8.03M | — |
| Bellerophon Therapeutics Inc | New | +553,250 | +$6.06M | 70.8% |
| Bellerophon Therapeutics Inc | Exited | −8,298,755 | −$2.9M | — |
| EB Ekso Bionics Hldgs Inc | New | +774,400 | +$2.19M | 25.6% |
| Tracon Pharmaceuticals Inc | Exited | −76,048 | −$178K | — |
| KH Kadmon Hldgs Inc | New | +30,000 | +$126K | 1.5% |
| Scynexis Inc | Trimmed | −40,790 | −$31.8K | 0.8% |
| Tracon Pharmaceuticals Inc | New | +18,107 | +$31K | 0.4% |
quarter ended December 31, 2019 · filed February 14, 2020
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Tracon Pharmaceuticals Inc | Trimmed | −4,525,720 | −$10.6M | 0.4% |
| KH Kadmon Hldgs Inc | Exited | −3,020,596 | −$7.53M | — |
| Scynexis Inc | Trimmed | −251,946 | −$228K | 0.3% |
quarter ended September 30, 2019 · filed November 14, 2019
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Corvus Pharmaceuticals Inc | Trimmed | −246,859 | −$740K | 0.3% |
quarter ended June 30, 2019 · filed August 13, 2019
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Scynexis Inc | New | +378,811 | +$496K | 0.5% |
quarter ended March 31, 2019 · filed May 14, 2019
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| KH Kadmon Hldgs Inc | Trimmed | −1,478,756 | −$3.9M | 6.5% |
| SS SPDR Series Trust | Exited | −9,986 | −$716K | — |
quarter ended December 31, 2018 · filed February 14, 2019
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| KH Kadmon Hldgs Inc | Added | +677,302 | +$1.41M | 10.7% |
| Corvus Pharmaceuticals Inc | New | +284,869 | +$1.05M | 1.2% |
| SS SPDR Series Trust | New | +9,986 | +$716K | 0.8% |
Loading...
